A Phase II Study of Neoadjuvant Chemotherapy + IMRT Combined With Cetuximab in Advanced T Stage of Nasopharyngeal Carcinoma

Trial Profile

A Phase II Study of Neoadjuvant Chemotherapy + IMRT Combined With Cetuximab in Advanced T Stage of Nasopharyngeal Carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Apr 2016

At a glance

  • Drugs Cetuximab (Primary) ; Antineoplastics
  • Indications Nasopharyngeal cancer
  • Focus Therapeutic Use
  • Acronyms REPLACE
  • Most Recent Events

    • 12 Aug 2011 Planned end date changed from 1 Oct 2013 to 1 Oct 2014 as reported by ClinicalTrials.gov.
    • 31 Jan 2011 Primary endpoints added as reported by ClinicalTrials.gov record.
    • 11 Jan 2011 Trial sponsor and lead trial centre (Merck and Co, China) added as reported by Chinese Clinical Trial Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top